Chen Wei-Che, Chen I-Chieh, Chen Jun-Peng, Liao Tsai-Ling, Chen Yi-Ming
Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, Taiwan.
Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
PeerJ. 2024 Feb 28;12:e17066. doi: 10.7717/peerj.17066. eCollection 2024.
Invasive pulmonary aspergillosis (IPA) affects immunocompromised hosts and is associated with higher risks of respiratory failure and mortality. However, the clinical outcomes of different IPA types have not been identified.
Between September 2002 and May 2021, we retrospectively enrolled patients with IPA in Taichung Veterans General Hospital, Taiwan. Cases were classified as possible IPA, probable IPA, proven IPA, and putative IPA according to EORTC/MSGERC criteria and the AspICU algorithm. Risk factors of respiratory failure, kidney failure, and mortality were analyzed by logistic regression. A total of 3-year survival was assessed by the Kaplan-Meier method with log-rank test for comparisons.
We included 125 IPA patients (50: possible IPA, 47: probable IPA, 11: proven IPA, and 17: putative IPA). Comorbidities of liver cirrhosis and solid organ malignancy were risk factors for respiratory failure; diabetes mellitus and post-liver or kidney transplantation were related to kidney failure. Higher galactomannan (GM) test optical density index (ODI) in either serum or bronchoalveolar lavage fluid was associated with dismal outcomes. Probable IPA and putative IPA had lower 3-year respiratory failure-free survival compared to possible IPA. Probable IPA and putative IPA exhibited lower 3-year renal failure-free survival in comparison to possible IPA and proven IPA. Putative IPA had the lowest 3-year overall survival rates among the four IPA groups.
Patients with putative IPA had higher mortality rates than the possible, probable, or proven IPA groups. Therefore, a prompt diagnosis and timely treatment are warranted for patients with putative IPA.
侵袭性肺曲霉病(IPA)影响免疫功能低下的宿主,并与呼吸衰竭和死亡的较高风险相关。然而,不同类型IPA的临床结局尚未明确。
2002年9月至2021年5月期间,我们对台湾台中荣民总医院的IPA患者进行了回顾性研究。根据欧洲癌症研究与治疗组织/侵袭性真菌感染协作组(EORTC/MSGERC)标准和重症监护病房曲霉病(AspICU)算法,将病例分为可能的IPA、很可能的IPA、确诊的IPA和疑似IPA。通过逻辑回归分析呼吸衰竭、肾衰竭和死亡的危险因素。采用Kaplan-Meier法评估3年总生存率,并进行对数秩检验以作比较。
我们纳入了125例IPA患者(50例:可能的IPA,47例:很可能的IPA,11例:确诊的IPA,17例:疑似IPA)。肝硬化和实体器官恶性肿瘤的合并症是呼吸衰竭的危险因素;糖尿病以及肝或肾移植术后与肾衰竭有关。血清或支气管肺泡灌洗液中较高的半乳甘露聚糖(GM)检测光密度指数(ODI)与不良结局相关。与可能的IPA相比,很可能的IPA和疑似IPA的3年无呼吸衰竭生存率较低。与可能的IPA和确诊的IPA相比,很可能的IPA和疑似IPA的3年无肾衰竭生存率较低。疑似IPA在四个IPA组中的3年总生存率最低。
疑似IPA患者的死亡率高于可能的、很可能的或确诊的IPA组。因此,对于疑似IPA患者,需要及时诊断和治疗。